We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
ACCEPT Reject
Already have an account? Sign in.

 Remember Me | Forgot Your Password?
Home Manage Alerts Archive Archive About Us Register Now   Not a User? Join now

J&J Acquires Japan’s Ci:z Holdings And Its Skincare And Dermocosmetic Brands

October 23, 2018: 12:00 AM EST
Johnson & Johnson has announced an agreement to acquire all outstanding shares it doesn’t already own in Ci:z Holdings Co., Ltd., a Japanese skincare and dermocosmetic company, for some ¥230 billion (about US$2 billion). The deal includes brands like Genomer, Dr.Ci:Labo and Labo Labo. One of the benefits cited by J&J is improving its online commerce capabilities by “leveraging one of the largest customer relationship management databases for direct-to-consumer skincare in Japan”. The offer is expected to close early next year.[Image Credit: © Ci:z Holdings]
"Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd.", Johnson & Johnson, October 23, 2018, © Johnson & Johnson Services, Inc
Domains
PERSONAL CARE BUSINESS
Brands
Market News
Market Segments
Strategy
Skin Care
Geographies
Worldwide
North America
Asia-Pacific
United States of America
Japan
Categories
Companies
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Products & Brands
Home | Privacy Policy | Terms and Conditions | Contact Us Copyright © 2000-2023 Business360 Inc. All Rights Reserved
Developed by Yuri Ingultsov Software Lab.